Skip to main content

Table 1 Demographic and clinical characteristics on study subjects

From: ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s disease

 

CN (n = 50)

MCI (n = 18)

AD (n = 40)

P-value

Age

   

0.422

 Mean (SD)

68.8 (9.95)

70.5 (5.94)

71.3 (9.37)

 Median [min, max]

68.2 [48.9, 88.1]

67.9 [62.9, 83.1]

72.7 [51.4, 86.9]

Sex

   

0.044 *

 Female

30 (58.8%)

4 (25.0%)

24 (58.5%)

 Male

21 (41.2%)

12 (75.0%)

17 (41.5%)

Race

   

0.23

 Black

7 (13.7%)

0 (0%)

2 (4.9%)

 White

44 (86.3%)

16 (100%)

38 (92.7%)

 Asian

0 (0%)

0 (0%)

1 (2.4%)

MMSE Total

   

9.33E−18***

 Mean (SD)

29.1 (1.20)

27.1 (1.83)

20.6 (5.78)

 Median [min, max]

30.0 [25.0, 30.0]

27.0 [23.0, 30.0]

22.0 [5.00, 30.0]

 Missing

1 (2.0%)

1 (6.2%)

1 (2.4%)

Education

   

0.424

 Mean (SD)

16.3 (2.75)

15.6 (3.33)

15.6 (2.93)

 Median [min, max]

16.0 [12.0, 20.0]

16.0 [9.00, 20.0]

16.0 [11.0, 20.0]

  1. P-values were calculated using ANOVA; significant P-values: *P < 0.05; **P < 0.01; ***P < 0.001; CN cognitive normal, MCI mid cognitive impairment, AD Alzheimer’s disease, MMSE Mini-Mental State Examination